Economic Evaluation of Hepatitis C Treatment Extension to Acute Infection and Early-Stage Fibrosis Among Patients Who Inject Drugs in Developing Countries: A Case of China

Economic Evaluation of Hepatitis C Treatment Extension to Acute Infection and Early-Stage Fibrosis Among Patients Who Inject Drugs in Developing Countries: A Case of China

We aimed to assess the cost-effectiveness of (1) treating acute hepatitis C virus (HCV) vs. deferring treatment until the chronic phase and (2) treating all chronic patients vs. only those with advanced fibrosis; among Chinese genotype 1b treatment-naïve patients who injected drugs (PWID),...

Full description

Bibliographic Details
Main Authors: Yin Liu, Hui Zhang, Lei Zhang, Xia Zou, Li Ling
Format: Article
Language:English
Published: MDPI AG 2020-01-01
Series:International Journal of Environmental Research and Public Health
Subjects:
hepatitis c virus
cost-effectiveness
antiviral treatment
people who inject drugs
Online Access:https://www.mdpi.com/1660-4601/17/3/800

Internet

https://www.mdpi.com/1660-4601/17/3/800

Similar Items